Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.

BACKGROUND: The antithrombotic efficacy of aspirin is attributed to its inhibition of the enzyme prostaglandin G/H synthase, which is necessary for the formation of thromboxane A2 in platelets. Thromboxane A2 is a potent vasoconstrictor and platelet agonist. However, the formation of prostacyclin by...

全面介绍

书目详细资料
Main Authors: Clarke, R, Mayo, G, Price, P, FitzGerald, G
格式: Journal article
语言:English
出版: 1991

相似书籍